glp 1 drugs and pregnancy A study in the Journal of American Medicine shows new research on patients who stopped taking GLP-1 before or during pregnancy. CBS News medical contributor Dr. Celine Gounder explains the results Study: GLP-1 drugs and pregnancy

Rather, GLP-1 therapies appear to support the biological environment in which these processes unfold

Levy J, Atkinson AB, Bell PM, McCance DR, Hadden DR

The goal should be improved metabolic function, better body composition, and a lower-risk physiologic state

The study focused on two genetic variants that affect the enzyme peptidyl-glycine alpha-amidating monooxygenase (PAM)

Professional Enquiry B2B Research Enquiries Only If you represent a qualified institution and wish to initiate a compliance-reviewed discussion, please provide: Thank you

Importantly, meta-analyses of randomized controlled trials have generally not shown a statistically significant increased risk of pancreatitis with GLP-1 receptor agonists as a class